| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.8M | -34.1% |
| Operating Income | -$11.1M | +21.5% |
| Net Income | -$11.4M | +20.6% |
| EPS (Basic) | -$9.50 | +40.7% |
| EPS (Diluted) | -$8.79 | +45.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.4M | -24.7% |
| Current Assets | $6.7M | -36.4% |
| Total Assets | $6.8M | -38.5% |
| Current Liabilities | $1.4M | +59.9% |
| Total Liabilities | $1.6M | +48.5% |
| Stockholders' Equity | $5.1M | -48.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.3M | +23.1% |
| Investing Cash Flow | $1.2M | +802.5% |
| Financing Cash Flow | $6.0M | -66.8% |